|
|
| MRD / Regn No. |
: 324 |
Date |
: 18/06/2026 |
| Patient Name |
: Purabi Das |
Age & Gender |
: 64 Yrs. / Female |
| Contact No. |
: 9735577395 |
UHID |
: |
| Ht / Wt / BMI |
: 149 / 75 / 33.78 |
BP S / BP D |
: 111 / 66 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (31/Oct/2010) | HYPERTENSION (31/Oct/2022) | |
| Salient Investigations |
: |
POTASSIUM: 4.01 | CREATININE: 0.86 | EGFR EGLOMERULAR FILTRATION RATE: 71.12 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 117 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 7.9 % | MICROALBUMIN CREATININE RATIO: 49 mcg/mg |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TELMISARTAN 80 MG + AMLODIPINE 5 MG
TELDAY AM 80/5 MG |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
2 |
TABLET ROSUVASTATIN 10 MG
STATEZE R |
PO |
0-0-1 |
BEFORE DINNER
|
|
|
|
3 |
GLICLAZIDE 80 MG + METFORMIN 500 MG
CYBLEX M 80 MG |
PO |
1-0-1 |
BEFORE BREAKFAST AND DINNER
|
TILL NEXT VISIT |
|
|
4 |
INJECTION SEMAGLUTIDE 0.25 MG
NOVELTREAT 0.25 |
SC |
ONCE A WEEK |
AFTER BREAKFAST
|
TILL NEXT VISIT |
|
|
5 |
ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
ZEXRIDA 10 |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 18/Dec/2026 |
| Tests Suggested For Next Visit |
: HBA1C-HPLC METHOD,UACR:SPOT SAMPLE,CREATININE,POTASSIUM |
| |
|
| |
|
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal /
54020
This is a Computer generated Prescription |
Powered By:  |